Some PET studies suggest a lower basal dopaminergic tone in ADHD, based on a higher density of the dopamine transporter DAT1 in non-treated patients, which is normalized after medication (Krause et al., 2000; Spencer et al., 2005). The gene discussed is SLC6A3; the disease is attention deficit-hyperactivity disorder.